Thierry Mauvernay is President of Après-demain, the parent company of Debiopharm, a Swiss, privately owned, biopharmaceutical company founded by his father over 40 years ago. Après-demain invests in a variety of industries including companies impacting sustainable energy, education, food, and services to individuals with real estate. Mauvernay is also Chairman of the investment committee of Debiopharm Innovation Fund. He holds a Master of Science in Economics and Marketing and an MBA from the Institut d’Administration des Entreprises.
Latest news
X
Log in or register to enjoy the full experience
Explore first person business intelligence from top minds curated for a global executive audience